Literature DB >> 24018259

Secondary prevention of venous thromboembolism.

Sam Schulman1, James Douketis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24018259     DOI： 10.1136/bmj.f5440

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy.

Authors:  Allison P Wheeler; David Gailani
Journal:  Hematol Oncol Clin North Am       Date:  2016-10       Impact factor: 3.722

Review 2.  Factor XI and contact activation as targets for antithrombotic therapy.

Authors:  D Gailani; C E Bane; A Gruber
Journal:  J Thromb Haemost       Date:  2015-06-16       Impact factor: 5.824

3.  Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment.

Authors:  Vincent Ten Cate; Brigitte Ab Essers; Martin H Prins
Journal:  BMJ Open       Date:  2017-05-10       Impact factor: 2.692

4.  Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS).

Authors:  Arina J ten Cate-Hoek; Jeffrey I Weitz; David Gailani; Karina Meijer; Helen Philippou; Annemieke C Bouman; Y Whitney Cheung; Thijs E van Mens; Jose W Govers-Riemslag; Minka Vries; Suzanne Bleker; Jossi S Biedermann; S Carina M Stoof; Harry R Buller
Journal:  Thromb Res       Date:  2015-09       Impact factor: 3.944

5.  Secondary prophylaxis decision-making in venous thromboembolism: interviews on clinical practice in thirteen countries.

Authors:  Vincent Ten Cate; Martin H Prins
Journal:  Res Pract Thromb Haemost       Date:  2017-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.